Bibliographic Details
| Title: |
Efficacy and Safety of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) With High-Risk (HR) Features: A Subgroup Analysis From the Phase 1/2 MajesTEC-1 Study |
| Authors: |
Costa, Luciano J, Bahlis, Nizar J, Usmani, Saad Z, WCJ van de Donk, Niels, Nooka, Ajay K, Perrot, Aurore, Qi, Keqin, Hodin, Caroline, Uhlar, Clarissa, Zuppa, Athena, Chastain, Katherine, Doyle, Margaret, Mateos, María-Victoria |
| Source: |
In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S235-S235 |
| Database: |
ScienceDirect |
